Targeting angiogenesis in pancreatic cancer
- PMID: 18514302
- DOI: 10.1016/S0140-6736(08)60770-9
Targeting angiogenesis in pancreatic cancer
Comment on
-
Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study.Lancet. 2008 Jun 21;371(9630):2101-8. doi: 10.1016/S0140-6736(08)60661-3. Epub 2008 May 29. Lancet. 2008. PMID: 18514303 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
